Authors/Disclosures
|
Alberto Maud, MD
(Paul L. Foster School of Medicine Texas Tech UHSC El Paso, Texas)
|
Dr. Maud has nothing to disclose. |
|
|
No disclosure on file |
|
Robert A. Taylor, MD
(Robert A. Taylor, MD, Inc.)
|
No disclosure on file |
|
Victoria Leavitt, PhD, FAAN
(Columbia University Irving Medical Center)
|
Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care. |
|
Hamza I. Maqsood, MD
(Dept of Neurology)
|
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
|
David C. Anderson, MD, FAAN
(Retired)
|
No disclosure on file |
|
Julia Koehn, MD
(University of Erlangen-Nuremberg)
|
No disclosure on file |
|
Mustapha A. Ezzeddine, MD, FAAN
(Wake Forest Baptist Health)
|
The institution of Dr. Ezzeddine has received research support from NIH. |